Why Oversight Without Ownership Is Not Governance

The Pattern Is Predictable When a healthcare organization recognizes that AI carries risk, the response follows a familiar sequence. A committee forms. A charter gets written. Meetings are scheduled. The intent is legitimate. The structure is not sufficient. Committees are built for deliberation. AI systems operate through execution. That mismatch is where accountability disappears. Deliberation produces recommendations. Execution requires decisions that persist after the meeting ends, decisions attached to names, not bodies. That distinction is where governance structures most often break down. The Questions That Expose the Gap When an AI system influences care, documentation, or clinical prioritization, three questions determine whether governance is real or performative. Who approved this deployment? What performance thresholds were validated before it went live? Which executive accepted the risk on behalf of this organization? When those questions are asked after an adverse event, the record frequently produces deliberation rather than a named owner. Minutes are on file. Recommended conditions are documented. Concerns are logged. What is missing is an owner. That absence is not a documentation problem. It is a structural one. And it does not stay invisible. It surfaces the moment something goes wrong and every stakeholder in the room reaches for the record and finds deliberation where accountability should have been. What the Evidence Shows A 2026 peer-reviewed study published in npj Digital Medicine conducted a systematic review of 35 healthcare AI governance frameworks and found that post-deployment controls, including monitoring, auditability, and incident response, represent the most persistent gap across governance models regardless of organizational size or resource level. The authors concluded that existing frameworks frequently address pre-deployment review while leaving operational accountability structurally undefined after a system goes live. That finding deserves more than a passing read. It means the governance work most organizations have done, the reviews, the approvals, the risk assessments, addresses the period before a system touches a patient. Once it goes live, the structure that felt rigorous becomes largely silent. No named owner. No defined cadence for performance review. No clear authority to pause or withdraw the system if something shifts. A mapping review of the ethics literature on AI in healthcare, published in Social Science and Medicine, identified traceability as a foundational accountability concern. The authors found that the black box nature of AI development pipelines undermines existing accountability mechanisms, making it difficult to trace the source of algorithmic decisions and resulting harms. When something goes wrong, the diffusion of responsibility across institutions, vendors, and clinical workflows leaves no clear line to follow. That is not an abstract finding. It describes what happens inside a health system when an AI tool influences a documentation pattern, a prioritization decision, or a care pathway, and no one with authority is watching it continuously. The regulatory environment is now reflecting that gap directly. State legislatures across the country have moved to fill a federal void, and what they are requiring is not process. It is named responsibility. As of January 1, 2026, multiple states have enacted or expanded AI governance requirements that place disclosure and accountability obligations directly on practitioners and deployers, not on committees or working groups. Texas made the ownership requirement explicit. TRAIGA, effective January 1, 2026, requires healthcare practitioners to provide written patient disclosure of AI use before or at the time of service. The Texas Attorney General holds enforcement authority. The law does not reference committees. It references practitioners and deployers by name. Other states are moving in the same direction. The question regulators are asking is not whether a review process existed. It is who was responsible. Why Committees Cannot Carry This A committee reviews. It recommends. It documents. Once a system goes live, the committee steps back. Ownership moves to operations. Risk moves to clinicians. When something goes wrong, no single accountable owner exists. Minutes get referenced. Decisions get debated. Memory replaces authority. This is not a failure of diligence. It is a failure of design. In my experience working across large health systems, AI tools do not hold still between governance cycles. Models are updated. Use cases expand beyond their original scope. Integrations deepen into clinical workflows without triggering a formal review. By the time a committee reconvenes, the system has already influenced hundreds of encounters, documentation patterns have shifted, and clinician behavior has adapted around it. Based on that evidence and experience, governance that lags execution is not governance. It becomes retrospective commentary dressed in the language of oversight. The committee existed. The charter was signed. The minutes are on file. None of that answers the question that matters when harm occurs. The Question Every CEO Should Be Able to Answer When an AI system in your organization influences a clinical decision and something goes wrong, one question will be asked before any other. Who was responsible for this? A committee cannot answer that question. A charter cannot answer it. Meeting notes cannot answer it. A named executive can. If you cannot identify that person today for every AI system influencing clinical decisions in your organization, the governance structure you have built is not protecting you. It is creating a detailed record of how thoroughly your organization reviewed a risk that no one was ultimately assigned to own. That record will not serve you well when it matters most. Governance is not the process of deciding whether to deploy. It is the structure that remains after deployment, with named owners, defined authority, and continuous accountability. Until that structure exists, the committee is not governing AI. It is documenting the appearance of governance and assuming the distance will protect the organization. It will not.